Use of anti-CD19 maytansinoid immunoconjugate antibody for the treatment of B-cell malignancies symptoms

摘要

An anti-CD1 9 maytansinoid immunoconjugate is used for treating B-cell malignancies symptom, in particular Non-Hodgkin's lymphoma.